US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 SubvariantGlobeNewsWire • 03/25/22
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022The Motley Fool • 03/25/22
Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare ConferenceGlobeNewsWire • 03/02/22
After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Vir Biotechnology, Inc. (VIR)Zacks Investment Research • 03/01/22
Vir Biotechnology, Inc. (VIR) Q4 Earnings and Revenues Beat EstimatesZacks Investment Research • 02/25/22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 02/24/22
Vir Biotechnology, Inc. (VIR) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 02/17/22
Vir: Expansion Of Covid-19 Antiviral Drug And Hepatitis B Pipeline Makes It An Attractive BetSeeking Alpha • 02/12/22
Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022GlobeNewsWire • 02/10/22
GSK, Vir Say Their Covid Antibody Treatment Can Neutralize Fast-Spreading Omicron RelativeForbes • 02/10/22
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2GlobeNewsWire • 02/10/22
Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 157%: Here's is How to TradeZacks Investment Research • 02/08/22
Vir Biotechnology Appoints Johanna Friedl-Naderer as Executive Vice President and Chief Business Officer, GlobalGlobeNewsWire • 02/08/22